Skip to content
2000
  1. Home
  2. A-Z Publications
  3. The International Journal of Gastroenterology and Hepatology Diseases
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2666-2906
  • E-ISSN: 2666-2914

Abstract

Obesity is one of the major health problems of the modern era. Obesity has been associated with rapidly rising growth rates that affect every age group of the population indiscriminately, particularly the younger ones. Undoubtedly, it is necessary to identify increasingly effective therapies in order to avoid the possible complications of the syndrome. In this context, the microbiota can represent one of the therapeutic targets for the prevention and treatment of obesity. We highlight the role of the microbiota as a therapeutic target in obesity.

© 2022 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ijghd/10.2174/2666290601666211018120831
2022-04-01
2025-02-17

  • From This Site

    /content/journals/ijghd/10.2174/2666290601666211018120831
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AvolioE. GualtieriP. RomanoL. PecorellaC. FerraroS. PalmaG. Di RenzoL. De LorenzoA. Obesity and body composition in man and woman: Associated diseases and the new role of gut microbiota.Curr. Med. Chem.202027221622910.2174/092986732666619032611360730914014
     [Google Scholar]
  2. ApovianC.M. Obesity: Definition, comorbidities, causes, and burden.Am. J. Manag. Care2016227Suppl.s176s18527356115
     [Google Scholar]
  3. AbenavoliL. ScarpelliniE. ColicaC. BoccutoL. SalehiB. Sharifi-RadJ. AielloV. RomanoB. De LorenzoA. IzzoA.A. CapassoR. Gut microbiota and obesity: A role for probiotics.Nutrients20191111269010.3390/nu1111269031703257
     [Google Scholar]
  4. AbenavoliL. ProcopioA.C. ScarpelliniE. PolimeniN. AquilaI. LarussaT. BoccutoL. LuzzaF. Gut microbiota and non-alcoholic fatty liver disease: A narrative review.Rev. Recent Clin. Trials2021Online ahead of print10.23736/S2724‑5985.21.02896‑533871224
     [Google Scholar]
  5. AbenavoliL. LarussaT. CoreaA. ProcopioA.C. BoccutoL. DallioM. FedericoA. LuzzaF. Dietary polyphenols and non-alcoholic fatty liver disease.Nutrients202113249410.3390/nu1302049433546130
     [Google Scholar]
  6. ScarpelliniE. CazzatoA. LauritanoC. GabrielliM. LupascuA. GerardinoL. AbenavoliL. PetruzzellisC. GasbarriniG. GasbarriniA. Probiotics: Which and when?Dig. Dis.200826217518210.1159/00011677618431068
     [Google Scholar]
  7. Méndez-SánchezN. Valencia-RodríguezA. Vera-BarajasA. AbenavoliL. ScarpelliniE. Ponciano-RodríguezG. WangD.Q.H. The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer.Hepatoma Res.20206510.20517/2394‑5079.2019.2932582865
     [Google Scholar]
  8. MoldovanD.C. IsmaielA. FagooneeS. PellicanoR. AbenavoliL. DumitrascuD.L. Gut microbiota and cardiovascular diseases axis: A review.Minerva Med.2021Online ahead of print10.23736/S0026‑4806.21.07527‑333969961
     [Google Scholar]
  9. DaoM.C. EverardA. Aron-WisnewskyJ. SokolovskaN. PriftiE. VergerE.O. KayserB.D. LevenezF. ChillouxJ. HoylesL. DumasM.E. RizkallaS.W. DoréJ. CaniP.D. ClémentK. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology.Gut201665342643610.1136/gutjnl‑2014‑30877826100928
     [Google Scholar]
  10. DepommierC. EverardA. DruartC. PlovierH. Van HulM. Vieira-SilvaS. FalonyG. RaesJ. MaiterD. DelzenneN.M. de BarsyM. LoumayeA. HermansM.P. ThissenJ.P. de VosW.M. CaniP.D. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study.Nat. Med.20192571096110310.1038/s41591‑019‑0495‑231263284
     [Google Scholar]
  11. ArmougomF. HenryM. VialettesB. RaccahD. RaoultD. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients.PLoS One200949e712510.1371/journal.pone.000712519774074
     [Google Scholar]
  12. SantacruzA. ColladoM.C. García-ValdésL. SeguraM.T. Martín-LagosJ.A. AnjosT. Martí-RomeroM. LopezR.M. FloridoJ. CampoyC. SanzY. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women.Br. J. Nutr.20101041839210.1017/S000711451000017620205964
     [Google Scholar]
  13. SchwiertzA. TarasD. SchäferK. BeijerS. BosN.A. DonusC. HardtP.D. Microbiota and SCFA in lean and overweight healthy subjects.Obesity (Silver Spring)201018119019510.1038/oby.2009.16719498350
     [Google Scholar]
  14. KobyliakN. AbenavoliL. FalalyeyevaT. BeregovaT. Efficacy of probiotics and smectite in rats with non-alcoholic fatty liver disease.Ann. Hepatol.201817115316110.5604/01.3001.0010.754729311399
     [Google Scholar]
  15. SchützF. Figueiredo-BragaM. BarataP. Cruz-MartinsN. Obesity and gut microbiome: Review of potential role of probiotics.Porto Biomed. J.202161e11110.1097/j.pbj.000000000000011133490703
     [Google Scholar]
/content/journals/ijghd/10.2174/2666290601666211018120831
Loading

  • Article Type:     Editorial
Keyword(s): dysbiosis; Health; metabolism; obesity; pathogenesis; treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test